Abstract
Women with depressive symptoms during pregnancy are in great need of safe, inexpensive, non-pharmacologic, accessible, and effective adjunctive therapies to enhance well-being, reduce the burden of symptoms both during their pregnancy and into the postpartum period, and prevent chronic sequelae. Because maternal depressive symptoms are associated with a variety of poor maternal-child outcomes (e.g., poor maternal health behaviors, suicide, poor maternal-fetal/child attachment, intrauterine growth restriction, adult-onset chronic illnesses in offspring, among others), a focus on adequate symptom management during pregnancy is an urgent clinical and research priority. Prenatal yoga is a promising modality which involves gentle physical activity, breathing practices, and relaxation practices that may empower women to self-manage symptoms, enhance well-being, and reduce symptom burden during pregnancy and into the postpartum period. Continued high-quality research is warranted which uses established theoretical frameworks and which builds on my team’s and others’ preliminary research studies which have demonstrated that pregnant women prefer to play an active role in symptom management and that they view prenatal yoga as an accessible, preferred form of mindful physical activity. Yoga for depression in pregnancy 3.
Highlights
Women with depressive symptoms during pregnancy are in great need of safe, inexpensive, non-pharmacologic, accessible, and effective adjunctive therapies to enhance well-being, reduce the burden of symptoms both during their pregnancy and into the postpartum period, and prevent chronic sequelae
Appropriate treatment of depressive symptoms in pregnancy is essential, yet many women find the “usual care” (UC; antidepressant medications and psychotherapy) insufficient to address their symptoms, or they are concerned about stigma, cost, and side effects [16,25,26,27,28,29,30]
Because commonly-used antidepressant medications, such as selective serotonin reuptake inhibitors cross the placental barrier, many women and clinicians are concerned about the currently unknown long-term impact of antidepressant exposure on the child [31].Findings from preliminary studies suggest that in utero exposure to SSRIs may result in abnormal epigenetic patterns which may put the child at risk for poor health in the future [32]
Summary
Women with depressive symptoms during pregnancy are in great need of safe, inexpensive, non-pharmacologic, accessible, and effective adjunctive therapies to enhance well-being, reduce the burden of symptoms both during their pregnancy and into the postpartum period, and prevent chronic sequelae. Appropriate treatment of depressive symptoms in pregnancy is essential, yet many women find the “usual care” (UC; antidepressant medications and psychotherapy) insufficient to address their symptoms, or they are concerned about stigma, cost, and side effects [16,25,26,27,28,29,30]..
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.